{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T17:16:00Z","timestamp":1783617360618,"version":"3.55.0"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"27","license":[{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,7,3]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      The hemoglobin glycation index (HGI), which measures the difference between observed and predicted glycated hemoglobin, is strongly associated with diabetic complications. However, its relationship with new-onset diabetes in patients with chronic liver disease (CLD) remains unexplored. This study aimed to investigate this association using data from the China Health and Retirement Longitudinal Study database. This study included 329 participants aged \u226545 years with CLD from the China Health and Retirement Longitudinal Study database. HGI was calculated as glycated hemoglobin\u2005\u2212\u2005(0.013\u2005\u00d7\u2005fasting plasma glucose\u2005+\u20054.804). Based on baseline HGI levels, participants were categorized into 3 groups (Q1\u2013Q3). The primary endpoint was the occurrence of new-onset diabetes mellitus events. The Kaplan\u2013Meier curves, multivariable Cox proportional hazards models, and restricted cubic spline analysis were applied to explore the association between baseline HGI levels and the risk of diabetes mellitus incidence among individuals with CLD. In the adjusted multivariable Cox regression analysis, HGI was significantly associated with a 53% increased risk of diabetes (hazard ratio\u2005=\u20051.53, 95% confidence interval: 1.17\u20131.99,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.002). The Kaplan\u2013Meier curve analysis revealed a significant difference in the occurrence of diabetes mellitus among the HGI groups. Significant risk thresholds were identified at HGI\u2005=\u2005\u22120.94, beyond which diabetes mellitus risk increased substantially. Stratified and interaction analyses confirmed the stability of this association. An increase in baseline HGI levels was significantly associated with the risk of diabetes mellitus in individuals with CLD. HGI can be used as a potential indicator for predicting the long-term risk of diabetes incidence in such patients.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000049567","type":"journal-article","created":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T17:01:39Z","timestamp":1783098099000},"page":"e49567","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Association between hemoglobin glycation index and new-onset diabetes mellitus in individuals with chronic liver disease: Findings from a prospective cohort study using CHARLS data"],"prefix":"10.1097","volume":"105","author":[{"given":"Yanyan","family":"Mao","sequence":"first","affiliation":[{"name":"Department of Health Management Center, Hubei Provincial Hospital of Traditional Chinese Medicine, Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Kong","sequence":"additional","affiliation":[{"name":"Department of Health Management Center, Hubei Provincial Hospital of Traditional Chinese Medicine, Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Health Management Center, Hubei Provincial Hospital of Traditional Chinese Medicine, Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangyan","family":"Liao","sequence":"additional","affiliation":[{"name":"Department of Health Management Center, Hubei Provincial Hospital of Traditional Chinese Medicine, Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-1596-3283","authenticated-orcid":false,"given":"Xiangwen","family":"Li","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Hubei Provincial Hospital of Traditional Chinese Medicine, Wuhan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260709","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S2468-1253(19)30349-8","article-title":"The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017.","volume":"5","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R2-20260709","doi-asserted-by":"crossref","first-page":"e32608","DOI":"10.1097\/MD.0000000000032608","article-title":"Prevalence and global trends of polypharmacy in patients with chronic liver disease: a systematic review and meta-analysis.","volume":"102","author":"Danjuma","year":"2023","journal-title":"Medicine (Baltimore)"},{"key":"R3-20260709","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/s41575-025-01099-z","article-title":"Liver, ageing and disease.","volume":"22","author":"Le Couteur","year":"2025","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R4-20260709","doi-asserted-by":"crossref","first-page":"e35208","DOI":"10.1097\/MD.0000000000035208","article-title":"Real-world use of avatrombopag in patients with chronic liver disease and thrombocytopenia undergoing a procedure.","volume":"102","author":"Satapathy","year":"2023","journal-title":"Medicine (Baltimore)"},{"key":"R5-20260709","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1097\/CM9.0000000000003726","article-title":"Global and Chinese burden of non-alcoholic fatty liver disease in chronic liver disease: findings from the Global Burden of Disease Study 2021.","volume":"138","author":"Zhao","year":"2025","journal-title":"Chin Med J (Engl)"},{"key":"R6-20260709","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.cell.2021.04.015","article-title":"Mechanisms and disease consequences of nonalcoholic fatty liver disease.","volume":"184","author":"Loomba","year":"2021","journal-title":"Cell"},{"key":"R7-20260709","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.jhep.2022.11.010","article-title":"A prospective study on the prevalence of NAFLD, advanced fibrosis, cirrhosis and hepatocellular carcinoma in people with type 2 diabetes.","volume":"78","author":"Ajmera","year":"2023","journal-title":"J Hepatol"},{"key":"R8-20260709","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.2337\/dci24-0094","article-title":"Metabolic dysfunction-associated steatotic liver disease (MASLD) in people with diabetes: the need for screening and early intervention. A consensus report of the American Diabetes Association.","volume":"48","author":"Cusi","year":"2025","journal-title":"Diabetes Care"},{"key":"R9-20260709","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1097\/HEP.0000000000000913","article-title":"Epidemiology, screening, and co-management of type 2 diabetes mellitus and metabolic dysfunction-associated steatotic liver disease.","volume":"83","author":"Qi","year":"2026","journal-title":"Hepatology"},{"key":"R10-20260709","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.jhep.2025.02.033","article-title":"Integrative metabolism in MASLD and MASH: pathophysiology and emerging mechanisms.","volume":"83","author":"Steinberg","year":"2025","journal-title":"J Hepatol"},{"key":"R11-20260709","doi-asserted-by":"crossref","first-page":"e70125","DOI":"10.1002\/jev2.70125","article-title":"Umbilical cord-mesenchymal stromal cell-derived extracellular vesicles target the liver to improve neurovascular health in type 2 diabetes with non-alcoholic fatty liver disease.","volume":"14","author":"Du","year":"2025","journal-title":"J Extracell Vesicles"},{"key":"R12-20260709","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.3350\/cmh.2024.1096","article-title":"Glucagon-like peptide 1 receptor agonist and reduced liver and non-liver complications in adults with type 2 diabetes and metabolic dysfunction-associated steatotic liver disease: a target trial emulation study.","volume":"31","author":"Mao","year":"2025","journal-title":"Clin Mol Hepatol"},{"key":"R13-20260709","doi-asserted-by":"crossref","first-page":"1094101","DOI":"10.3389\/fendo.2023.1094101","article-title":"Association between hemoglobin glycation index and non-alcoholic fatty liver disease.","volume":"14","author":"Xing","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R14-20260709","doi-asserted-by":"crossref","first-page":"5498","DOI":"10.1111\/dom.16592","article-title":"HbA1c reduction with tirzepatide in people with type 2 diabetes: the contribution of weight loss assessed by a mediation analysis.","volume":"27","author":"Vilsb\u00f8ll","year":"2025","journal-title":"Diabetes Obes Metab"},{"key":"R16-20260709","doi-asserted-by":"crossref","first-page":"112936","DOI":"10.1016\/j.diabres.2025.112936","article-title":"Diabetic retinopathy and mortality in adults with diabetes: causal mediation analysis of the role of HbA1c.","volume":"229","author":"Wang","year":"2025","journal-title":"Diabetes Res Clin Pract"},{"key":"R17-20260709","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.2147\/DMSO.S523442","article-title":"Association between the hemoglobin glycation index (HGI) and risk of diabetic nephropathy: a retrospective cohort study.","volume":"18","author":"Zhou","year":"2025","journal-title":"Diabetes Metab Syndr Obes"},{"key":"R18-20260709","doi-asserted-by":"crossref","first-page":"e002339","DOI":"10.1136\/bmjdrc-2021-002339","article-title":"Hemoglobin glycation index, calculated from a single fasting glucose value, as a prediction tool for severe hypoglycemia and major adverse cardiovascular events in DEVOTE.","volume":"9","author":"Klein","year":"2021","journal-title":"BMJ Open Diabetes Res Care"},{"key":"R19-20260709","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1210\/clinem\/dgab703","article-title":"High hemoglobin glycation index is associated with telomere attrition independent of HbA1c, mediated by TNF\u03b1.","volume":"107","author":"Lyu","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"R20-20260709","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1111\/jdi.14066","article-title":"Association between hemoglobin glycation index and non-alcoholic fatty liver disease in the patients with type 2 diabetes mellitus.","volume":"14","author":"Wang","year":"2023","journal-title":"J Diabetes Investig"},{"key":"R21-20260709","doi-asserted-by":"crossref","first-page":"e70092","DOI":"10.1111\/jch.70092","article-title":"The association between the hemoglobin glycation index and cardiometabolic diseases: a mini-review.","volume":"27","author":"Wu","year":"2025","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"R22-20260709","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1016\/j.cgh.2025.02.006","article-title":"High global prevalence of steatotic liver disease and associated subtypes: a meta-analysis.","volume":"23","author":"Ho","year":"2025","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R23-20260709","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/s12933-026-03195-z","article-title":"LDL-C combined with Chinese visceral adiposity index as a risk stratification tool for cardiometabolic multimorbidity in middle-aged and older Chinese adults: a national prospective cohort study.","volume":"25","author":"Shao","year":"2026","journal-title":"Cardiovasc Diabetol"},{"key":"R24-20260709","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","article-title":"2018 ESC\/ESH guidelines for the management of arterial hypertension.","volume":"39","author":"Williams","year":"2018","journal-title":"Eur Heart J"},{"key":"R25-20260709","doi-asserted-by":"crossref","first-page":"e34638","DOI":"10.1097\/MD.0000000000034638","article-title":"Mendelian randomization explores the causal relationships between obesity, diabetes, inflammation and nonalcoholic fatty liver disease.","volume":"102","author":"Wang","year":"2023","journal-title":"Medicine (Baltimore)"},{"key":"R26-20260709","first-page":"766","article-title":"Diabetes and NAFLD: a synergistic threat to metabolic health.","volume":"15","author":"Chaudhary","year":"2025","journal-title":"Adv Pharm Bull"},{"key":"R27-20260709","doi-asserted-by":"crossref","first-page":"1677175","DOI":"10.3389\/fendo.2025.1677175","article-title":"Microbiome-mediated crosstalk between T2DM and MASLD: a translational review focused on function.","volume":"16","author":"Jing","year":"2025","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R28-20260709","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1186\/s12951-025-03769-1","article-title":"Lipid metabolism and lipid signaling in extracellular vesicles ontogeny: from biogenesis to functional execution.","volume":"23","author":"Zhang","year":"2025","journal-title":"J Nanobiotechnol"},{"key":"R29-20260709","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1002\/hep.31806","article-title":"Glycemic control predicts severity of hepatocyte ballooning and hepatic fibrosis in nonalcoholic fatty liver disease.","volume":"74","author":"Alexopoulos","year":"2021","journal-title":"Hepatology"},{"key":"R30-20260709","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1111\/jdi.13455","article-title":"Mean and visit-to-visit variability of glycated hemoglobin, and the risk of non-alcoholic fatty liver disease.","volume":"12","author":"Yoo","year":"2021","journal-title":"J Diabetes Investig"},{"key":"R31-20260709","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1136\/gutjnl-2020-322572","article-title":"Non-alcoholic fatty liver disease and risk of incident diabetes mellitus: an updated meta-analysis of 501 022 adult individuals.","volume":"70","author":"Mantovani","year":"2021","journal-title":"Gut"},{"key":"R32-20260709","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3390\/v18020239","article-title":"Effect of direct-acting antiviral therapy on glycemic control in patients with chronic hepatitis C and type 2 diabetes: a systematic review and meta-analysis.","volume":"18","author":"Hu","year":"2026","journal-title":"Viruses"},{"key":"R33-20260709","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.eprac.2023.01.001","article-title":"Correlation between hemoglobin glycation index measured by continuous glucose monitoring with complications in type 1 diabetes.","volume":"29","author":"Ibarra-Salce","year":"2023","journal-title":"Endocr Pract"},{"key":"R34-20260709","doi-asserted-by":"crossref","first-page":"690689","DOI":"10.3389\/fcvm.2021.690689","article-title":"Association between hemoglobin glycation index and risk of cardiovascular disease and all-cause mortality in type 2 diabetic patients: a meta-analysis.","volume":"8","author":"Wu","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"R35-20260709","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s12933-024-02206-1","article-title":"Risk analysis of the association between different hemoglobin glycation index and poor prognosis in critical patients with coronary heart disease-a study based on the MIMIC-IV database.","volume":"23","author":"Wei","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"R36-20260709","doi-asserted-by":"crossref","first-page":"14791641231193306","DOI":"10.1177\/14791641231193306","article-title":"Association of hemoglobin glycation index with prognosis of coronary artery disease after percutaneous coronary intervention: a retrospective cohort study.","volume":"20","author":"Cheng","year":"2023","journal-title":"Diab Vasc Dis Res"},{"key":"R37-20260709","first-page":"1310","article-title":"Predictive value of hemoglobin glycation index for chronic kidney disease.","volume":"61","author":"Lin","year":"2022","journal-title":"Zhonghua Nei Ke Za Zhi"},{"key":"R38-20260709","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/s41574-025-01114-y","article-title":"Insulin resistance in type 2 diabetes mellitus.","volume":"21","author":"Accili","year":"2025","journal-title":"Nat Rev Endocrinol"},{"key":"R39-20260709","doi-asserted-by":"crossref","first-page":"7783","DOI":"10.3390\/ijms22157783","article-title":"Glucose variability: how does it work?","volume":"22","author":"Klimontov","year":"2021","journal-title":"Int J Mol Sci"},{"key":"R40-20260709","doi-asserted-by":"crossref","first-page":"158","DOI":"10.14789\/ejmj.JMJ25-0001-R","article-title":"Pancreatic \u03b2-cell dysfunction and diabetes.","volume":"71","author":"Iida","year":"2025","journal-title":"Juntendo Med J"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000049567","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T17:02:23Z","timestamp":1783616543000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000049567"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,3]]},"references-count":39,"journal-issue":{"issue":"27","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000049567","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,3]]},"assertion":[{"value":"2026-01-16","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-15","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}